This is an interesting editorial from the  BMJ specialist palliative care of how the limited evidence for subcuatneous furosemide in palliative cancer patients. The article highlights the importance for rigorous studies in palliative medicine to be done in the future to inform practice.

Subcutaneous furosemide in advanced heart failure: has clinical practice run ahead of the evidence base? — Beattie and Johnson 2 (1): 5 — BMJ Supportive & Palliative Care.